Table 3.
Impact of APCA positivity on hematological parameters in patients with HT.
| HT Patients APCA-Negative (n = 25) * |
HT Patients APCA-Positive (n = 10) * |
p Value | |
|---|---|---|---|
| Hb, g/dL | 13.3 (12.8–14.4) | 13.0 (12.1–13.4) | 0.242 |
| MCV, fl | 88.3 (82.6–90.0) | 91.1 (86.7–92.9) | 0.121 |
| RBC, n × 106/μL | 4.8 (4.6–5.2) | 4.5 (1.1–4.7) | 0.047 |
| WBC, n × 103/μL | 7.2 (5.3–9.0) | 6.8 (5.7–7.4) | 0.969 |
| RDW | 13.5 (12.9–13.8) | 13.2 (13.0–13.7) | 0.913 |
* HT patients without available hematological parameters were excluded from this secondary analysis. Hb, hemoglobin; MCV, mean corpuscular volume; RBC, red blood cells; WBC, white blood cells; RDW, red blood cells distribution width. The bold value denotes statistical significance at the p < 0.05 level.